Monoclonal antibody drugs are supposed to help people with mild to moderate COVID-19 avoid the hospital, but it can be a challenge to find out where the treatment is offered. NPR has heard from people across the country who have been frustrated by this. They include Shirley Wagoner, an 80-year-old who still hits the ski slopes and helps run the family plumbing business in Read More
The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19. Continue Reading NIH Halts Hydroxychloroquine Study; Read More
Richard Bright says he was removed from his post because of his "insistence" that the government spend funds on "safe and scientifically vetted solutions" to address the coronavirus. Continue Reading Federal Scientist Says He Read More